Clinical Trial Update: Evaluation of the Therapeutic Effect of Platelet Rich Plasma (PRP) in Periorbital Hyperpigmentation(POH) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the therapeutic effect of platelet-rich plasma (PRP) for periorbital hyperpigmentation is referenced, with status currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periorbital Hypermelanosis

Drugs mentioned

• Platelet-rich plasma (PRP)

Snippet

Sponsor: Assiut University | Conditions: Periorbital Hypermelanosis | Phase 3 | Status: UNKNOWN